Affinity purification of recombinant cholera toxin B subunit oligomer expressed inBacillus brevisfor potential human use as a mucosal adjuvant
Open Access
- 1 April 1998
- journal article
- Published by Oxford University Press (OUP) in FEMS Immunology & Medical Microbiology
- Vol. 20 (4) , 311-318
- https://doi.org/10.1111/j.1574-695x.1998.tb01141.x
Abstract
For use as a mucosal adjuvant for human vaccines, a simple method has been developed for the affinity purification of recombinant cholera toxin B subKeywords
This publication has 29 references indexed in Scilit:
- Systemic and mucosal immune responses of mice to aluminium-adsorbed or aluminium-non-adsorbed tetanus toxoid administered intranasally with recombinant cholera toxin B subunitVaccine, 1998
- Report of the Expert Panel VI Concerted efforts in the field of mucosal immunologyVaccine, 1996
- Community-based assessment of safety and immunogenicity of the whole cell plus recombinant B subunit (
WC rBS Vaccine, 1995 - Crystal structure of cholera toxin B‐pentamer bound to receptor GM1 pentasaccharideProtein Science, 1994
- Actions of cholera toxin and the prevention and treatment of choleraNature, 1981
- Receptor‐Specific Large‐Scale Purification of Cholera Toxin on Silica Beads Derivatized with LysoGM1 GangliosideEuropean Journal of Biochemistry, 1981
- The arrangement of subunits in chlorea toxinBiochemistry, 1976
- Chemistry of Cholera Toxin: The Subunit StructureThe Journal of Infectious Diseases, 1976
- Subunit Structure of Cholera ToxinJournal of General Microbiology, 1973
- Production of Highly Purified Choleragen and CholeragenoidThe Journal of Infectious Diseases, 1970